DNAJC12 as a Mediator Between ESR1 and ERBB4 in Breast Carcinoma Cells
- PMID: 33718139
- PMCID: PMC7943744
- DOI: 10.3389/fonc.2021.582277
DNAJC12 as a Mediator Between ESR1 and ERBB4 in Breast Carcinoma Cells
Abstract
Mutation of the DNAJC12 gene is typically associated with non-progressive Parkinsonism, but is also detectable in breast carcinoma where its contribution and mechanisms are unexplored. In breast carcinoma, ESR1 was positively correlated with DNAJC12 and ERBB4, and DNAJC12 was positively correlated with ERBB4. We used the GEO2R tool to compare differential gene expression of MCF-7 cells, following ESR1 knockdown (GEO database, E-GEOD-27473 array), and found decreased expression of DNAJC12 and ERBB4 in ESR1-silenced MCF-7 cells. The number of identical genes having correlativity with ESR1, DNAJC12, or ERBB4 was 12,165 (66.41%). These results suggest that ESR1 can promote the expression of DNAJC12 and ERBB4, and DNAJC12 can enhance the expression of ERBB4 in MCF-7 cells, implying that there may be a regulatory network among these three genes.
Keywords: DNAJC12; ERBB4; ESR1; breast carcinoma; signaling pathway.
Copyright © 2021 Lin, Wang, Ye, Xiong, Guo and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.Mol Med Rep. 2016 May;13(5):4494-8. doi: 10.3892/mmr.2016.5078. Epub 2016 Mar 31. Mol Med Rep. 2016. PMID: 27035115
-
microRNA-Dependent Modulation of Genes Contributes to ESR1's Effect on ERα Positive Breast Cancer.Front Oncol. 2020 May 15;10:753. doi: 10.3389/fonc.2020.00753. eCollection 2020. Front Oncol. 2020. PMID: 32500028 Free PMC article.
-
Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer.Ann Surg Oncol. 2019 Mar;26(3):836-844. doi: 10.1245/s10434-018-07149-y. Epub 2019 Jan 7. Ann Surg Oncol. 2019. PMID: 30617870
-
DNAJC12 in Monoamine Metabolism, Neurodevelopment, and Neurodegeneration.Mov Disord. 2024 Feb;39(2):249-258. doi: 10.1002/mds.29677. Epub 2023 Nov 28. Mov Disord. 2024. PMID: 38014588 Review.
-
Systems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspective.Mol Cancer Res. 2008 Jun;6(6):885-91. doi: 10.1158/1541-7786.MCR-07-0369. Mol Cancer Res. 2008. PMID: 18567793 Review.
Cited by
-
Downregulation of DNAJC12 Expression Predicts Worse Survival for ER-Positive Breast Cancer Patients.Biomark Insights. 2025 Feb 24;20:11772719251323095. doi: 10.1177/11772719251323095. eCollection 2025. Biomark Insights. 2025. PMID: 40008192 Free PMC article.
References
-
- Australian Institute of Health and Welfare 2019 . Cancer in Australia 2019. Cancer Ser (2019) 119:38–42. Cat. no. CAN 123. Canberra: AIHW.
-
- Czajka ML, Pfeifer C. Breast Cancer Surgery. In: . StatPearls. Treasure Island (FL: StatPearls; (2020).
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous